Addiction Science Network (2000)
http://www.addictionscience.net/ASNcpp.htm

Carter, R.J., Lione, L.A. et al (1999) Characterization of progressive motor deficits in mice transgenic for the human Huntington’s Disease mutation. J. Neuroscience 19(8):3248-3257

Collier, H.O.J. (1964) Analgesics, chap 8 in “Evaluation of Drug Activities: Pharmacometrics” Vol 1, pp183-203 Laurence and Bacharach eds. Academic Press

Conrad, CD, Lupien SJ et al (1997) The effects of Type 1 and Type II corticosteroid receptor agonists on exploratory behavior and spatial memory in the Y-maze. Brain Research 759:76-83.

Crawley, J.N. (1999) Behavioural phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioural tests. Brain Res 835:18-26

Crawley, J.N. (2000) What’s wrong with my mouse? Wiley-Liss

Deacon, RMJ, Bannerman DM et al (2002) Effects of cytotoxic hippocampal lesions in mice on a cognitive test battery. Behav Brain Res. Jun 15;133(1):57-68

Geyer, Krebs-Thomson, Braff & Swerdlow, Psychopharmacology 156, 117-154, 2001

Geyer and Markou, In: Psychopharmacology, the Fourth Generation of Progress, Raven Press, New York, 1995, pp787-798

Geyer, McIlwain & Paylor, Molecular Psychiatry 7, 1039-1053, 2002

Holmes, A. (2003) Mouse behavioural models of anxiety and depression

Steru, L., Chermat, R., Thierry, B., Mico, J.a. et al (1987) The automated tail suspension test: a computerised device that differentiates psychotropic drugs. 11(6):659-71.

Vaugeois, J-M., Passera, G., Zuccaro, F., and Costentin, J. (1997) Individual differences in response to imipramine in the mouse tail suspension test. 134:387-391.

Wang, Short, Ledent, Lawrence & Van den Buuse, Behavioural Brain Research 143, 201-207, 2003

Wenk, G.L. (2001) Current Protocols in Neuroscience, Wiley